메뉴 건너뛰기




Volumn 23, Issue 6, 2011, Pages 391-403

Generation and characterization of peptide mimotopes specific for anti erbb-2 monoclonal antibodies

Author keywords

Cancer; Epitope homolog; Her 2; Monoclonal antibody; Peptide vaccination

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY L 26; MONOCLONAL ANTIBODY N 12; PEPTIDE; UNCLASSIFIED DRUG;

EID: 79957866860     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr028     Document Type: Article
Times cited : (9)

References (56)
  • 1
    • 18344390418 scopus 로고    scopus 로고
    • ERBB receptors and cancer: the complexity of targeted inhibitors
    • Hynes, N. E. and Lane, H. A. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5:341.
    • (2005) Nat. Rev. Cancer , vol.5 , pp. 341
    • Hynes, N.E.1    Lane, H.A.2
  • 3
    • 33745057881 scopus 로고    scopus 로고
    • HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer
    • Cappuzzo, F., Bemis, L. and Varella-Garcia, M. 2006. HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer. N. Engl. J. Med. 354:2619.
    • (2006) N. Engl. J. Med. , vol.354 , pp. 2619
    • Cappuzzo, F.1    Bemis, L.2    Varella-Garcia, M.3
  • 4
    • 33745727112 scopus 로고    scopus 로고
    • HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors
    • Wang, S. E., Narasanna, A., Perez-Torres, M. et al. 2006. HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell 10:25.
    • (2006) Cancer Cell , vol.10 , pp. 25
    • Wang, S.E.1    Narasanna, A.2    Perez-Torres, M.3
  • 5
    • 13844306484 scopus 로고    scopus 로고
    • Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy
    • Friedman, L. M., Rinon, A., Schechter, B. et al. 2005. Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. Proc. Natl Acad. Sci. USA 102:1915.
    • (2005) Proc. Natl Acad. Sci. USA , vol.102 , pp. 1915
    • Friedman, L.M.1    Rinon, A.2    Schechter, B.3
  • 6
    • 0033608993 scopus 로고    scopus 로고
    • The ErbB-2/ HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
    • Klapper, L. N., Glathe, S., Vaisman, N. et al. 1999. The ErbB-2/ HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc. Natl Acad. Sci. USA 96:4995.
    • (1999) Proc. Natl Acad. Sci. USA , vol.96 , pp. 4995
    • Klapper, L.N.1    Glathe, S.2    Vaisman, N.3
  • 7
    • 3543024857 scopus 로고
    • Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen
    • Drebin, J. A., Link, V. C., Weinberg, R. A. and Greene, M. I. 1986. Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proc. Natl Acad. Sci. USA 83:9129.
    • (1986) Proc. Natl Acad. Sci. USA , vol.83 , pp. 9129
    • Drebin, J.A.1    Link, V.C.2    Weinberg, R.A.3    Greene, M.I.4
  • 8
    • 0026610881 scopus 로고
    • Humanization of an anti-p185HER2 antibody for human cancer therapy
    • Carter, P., Presta, L., Gorman, C. M. et al. 1992. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl Acad. Sci. USA 89:4285.
    • (1992) Proc. Natl Acad. Sci. USA , vol.89 , pp. 4285
    • Carter, P.1    Presta, L.2    Gorman, C.M.3
  • 9
    • 34248641115 scopus 로고    scopus 로고
    • Cancer therapeutic antibodies come of age: targeting minimal residual disease
    • Ben-Kasus, T., Schechter, B., Sela, M. and Yarden, Y. 2007. Cancer therapeutic antibodies come of age: targeting minimal residual disease. Mol. Oncol. 1:42.
    • (2007) Mol. Oncol. , vol.1 , pp. 42
    • Ben-Kasus, T.1    Schechter, B.2    Sela, M.3    Yarden, Y.4
  • 10
    • 2942592008 scopus 로고    scopus 로고
    • Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib
    • Burris, H. A., 3rd 2004. Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib. Oncologist 9 (Suppl. 3):10.
    • (2004) Oncologist , vol.9 , Issue.SUPPL. 3 , pp. 10
    • Burris H.A., 3rd.1
  • 11
    • 0034076307 scopus 로고    scopus 로고
    • Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
    • Clynes, R. A., Towers, T. L., Presta, L. G. and Ravetch, J. V. 2000. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. 6:443.
    • (2000) Nat. Med. , vol.6 , pp. 443
    • Clynes, R.A.1    Towers, T.L.2    Presta, L.G.3    Ravetch, J.V.4
  • 12
    • 65349101151 scopus 로고    scopus 로고
    • Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzu-mab and is effectively inhibited by the PI3K inhibitor GDC-0941
    • Junttila, T. T., Akita, R. W., Parsons, K. et al. 2009. Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzu-mab and is effectively inhibited by the PI3K inhibitor GDC-0941. Cancer Cell 15:429.
    • (2009) Cancer Cell , vol.15 , pp. 429
    • Junttila, T.T.1    Akita, R.W.2    Parsons, K.3
  • 13
    • 62549147841 scopus 로고    scopus 로고
    • Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis
    • Ben-Kasus, T., Schechter, B., Lavi, S., Yarden, Y. and Sela, M. 2009. Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis. Proc. Natl Acad. Sci. USA 106:3294.
    • (2009) Proc. Natl Acad. Sci. USA , vol.106 , pp. 3294
    • Ben-Kasus, T.1    Schechter, B.2    Lavi, S.3    Yarden, Y.4    Sela, M.5
  • 14
    • 77949903478 scopus 로고    scopus 로고
    • Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy
    • 2010
    • Baselga, J., Gelmon, K. A., Verma, S. et al. 2009. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. J. Clin. Oncol. 28:1138. 2010.
    • (2009) J. Clin. Oncol. , vol.28 , pp. 1138
    • Baselga, J.1    Gelmon, K.A.2    Verma, S.3
  • 15
    • 42949157368 scopus 로고    scopus 로고
    • Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
    • Musolino, A., Naldi, N., Bortesi, B. et al. 2008. Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer. J. Clin. Oncol. 26:1789.
    • (2008) J. Clin. Oncol. , vol.26 , pp. 1789
    • Musolino, A.1    Naldi, N.2    Bortesi, B.3
  • 16
    • 73649149433 scopus 로고    scopus 로고
    • Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models
    • Scheuer, W., Friess, T., Burtscher, H., Bossenmaier, B., Endl, J. and Hasmann, M. 2009. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 69:9330.
    • (2009) Cancer Res , vol.69 , pp. 9330
    • Scheuer, W.1    Friess, T.2    Burtscher, H.3    Bossenmaier, B.4    Endl, J.5    Hasmann, M.6
  • 17
    • 0030959114 scopus 로고    scopus 로고
    • A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors
    • Klapper, L. N., Vaisman, N., Hurwitz, E., Pinkas-Kramarski, R., Yarden, Y. and Sela, M. 1997. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene 14:2099.
    • (1997) Oncogene , vol.14 , pp. 2099
    • Klapper, L.N.1    Vaisman, N.2    Hurwitz, E.3    Pinkas-Kramarski, R.4    Yarden, Y.5    Sela, M.6
  • 18
    • 33644600485 scopus 로고    scopus 로고
    • Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab
    • Adams, C. W., Allison, D. E., Flagella, K. et al. 2006. Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab. Cancer Immunol. Immun-other. 55:717.
    • (2006) Cancer Immunol. Immun-other. , vol.55 , pp. 717
    • Adams, C.W.1    Allison, D.E.2    Flagella, K.3
  • 19
    • 1842605531 scopus 로고    scopus 로고
    • Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
    • Franklin, M. C., Carey, K. D., Vajdos, F. F. et al. 2004. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5:317.
    • (2004) Cancer Cell , vol.5 , pp. 317
    • Franklin, M.C.1    Carey, K.D.2    Vajdos, F.F.3
  • 20
    • 0026091927 scopus 로고
    • Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth
    • Stancovski, I., Hurwitz, E., Leitner, O., Ullrich, A., Yarden, Y. and Sela, M. 1991. Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. Proc. Natl Acad. Sci. USA 88:8691.
    • (1991) Proc. Natl Acad. Sci. USA , vol.88 , pp. 8691
    • Stancovski, I.1    Hurwitz, E.2    Leitner, O.3    Ullrich, A.4    Yarden, Y.5    Sela, M.6
  • 21
    • 0032850677 scopus 로고    scopus 로고
    • Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
    • Cobleigh, M. A., Vogel, C. L., Tripathy, D. et al. 1999. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol. 17:2639.
    • (1999) J. Clin. Oncol. , vol.17 , pp. 2639
    • Cobleigh, M.A.1    Vogel, C.L.2    Tripathy, D.3
  • 22
    • 34247891741 scopus 로고    scopus 로고
    • More than one reason to rethink the use of peptides in vaccine design
    • Purcell, A. W., McCluskey, J. and Rossjohn, J. 2007. More than one reason to rethink the use of peptides in vaccine design. Nat. Rev. Drug Discov. 6:404.
    • (2007) Nat. Rev. Drug Discov. , vol.6 , pp. 404
    • Purcell, A.W.1    McCluskey, J.2    Rossjohn, J.3
  • 23
    • 0034054912 scopus 로고    scopus 로고
    • Peptide mimotopes as candidate vaccines
    • Partidos, C. D. 2000. Peptide mimotopes as candidate vaccines. Curr. Opin. Mol. Ther. 2:74.
    • (2000) Curr. Opin. Mol. Ther. , vol.2 , pp. 74
    • Partidos, C.D.1
  • 24
    • 54749157038 scopus 로고    scopus 로고
    • DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies
    • Whittington, P. J., Piechocki, M. P., Heng, H. H. et al. 2008. DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies. Cancer Res 68:7502.
    • (2008) Cancer Res , vol.68 , pp. 7502
    • Whittington, P.J.1    Piechocki, M.P.2    Heng, H.H.3
  • 25
    • 0027997807 scopus 로고
    • Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage-displayed peptides
    • Orlandi, R., Menard, S., Colnaghi, M. I., Boyer, C. M. and Felici, F. 1994. Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage-displayed peptides. Eur. J. Immunol. 24:2868.
    • (1994) Eur. J. Immunol. , vol.24 , pp. 2868
    • Orlandi, R.1    Menard, S.2    Colnaghi, M.I.3    Boyer, C.M.4    Felici, F.5
  • 26
    • 0034454290 scopus 로고    scopus 로고
    • Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library
    • Vaisman, N., Nissim, A., Klapper, L. N., Tirosh, B., Yarden, Y. and Sela, M. 2000. Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library. Immunol. Lett. 75:61.
    • (2000) Immunol. Lett. , vol.75 , pp. 61
    • Vaisman, N.1    Nissim, A.2    Klapper, L.N.3    Tirosh, B.4    Yarden, Y.5    Sela, M.6
  • 27
    • 0035871618 scopus 로고    scopus 로고
    • Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design
    • Yip, Y. L., Smith, G., Koch, J., Dubel, S. and Ward, R. L. 2001. Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design. J. Immunol. 166:5271.
    • (2001) J. Immunol. , vol.166 , pp. 5271
    • Yip, Y.L.1    Smith, G.2    Koch, J.3    Dubel, S.4    Ward, R.L.5
  • 28
    • 2942741136 scopus 로고    scopus 로고
    • Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu
    • Riemer, A. B., Klinger, M., Wagner, S. et al. 2004. Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. J. Immunol. 173:394.
    • (2004) J. Immunol. , vol.173 , pp. 394
    • Riemer, A.B.1    Klinger, M.2    Wagner, S.3
  • 29
    • 34249820537 scopus 로고    scopus 로고
    • Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu
    • Garrett, J. T., Rawale, S., Allen, S. D. et al. 2007. Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu. J. Immunol. 178:7120.
    • (2007) J. Immunol. , vol.178 , pp. 7120
    • Garrett, J.T.1    Rawale, S.2    Allen, S.D.3
  • 30
    • 77955555499 scopus 로고    scopus 로고
    • Identification and characterization of Ch806 mimotopes
    • Yang, L., Jiang, H., Shi, B. et al. 2010. Identification and characterization of Ch806 mimotopes. Cancer Immunol. Immun-other. 59:1481.
    • (2010) Cancer Immunol. Immun-other. , vol.59 , pp. 1481
    • Yang, L.1    Jiang, H.2    Shi, B.3
  • 31
    • 27944464948 scopus 로고    scopus 로고
    • Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies
    • Riemer, A. B., Kurz, H., Klinger, M., Scheiner, O., Zielinski, C. C. and Jensen-Jarolim, E. 2005. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies. J. Natl Cancer Inst. 97:1663.
    • (2005) J. Natl Cancer Inst. , vol.97 , pp. 1663
    • Riemer, A.B.1    Kurz, H.2    Klinger, M.3    Scheiner, O.4    Zielinski, C.C.5    Jensen-Jarolim, E.6
  • 32
    • 77955655880 scopus 로고    scopus 로고
    • Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response
    • Hartmann, C., Muller, N., Blaukat, A., Koch, J., Benhar, I. and Wels, W. S. 2010. Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response. Oncogene 29:4517.
    • (2010) Oncogene , vol.29 , pp. 4517
    • Hartmann, C.1    Muller, N.2    Blaukat, A.3    Koch, J.4    Benhar, I.5    Wels, W.S.6
  • 33
    • 0035874389 scopus 로고    scopus 로고
    • The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd
    • Enshell-Seijffers, D., Smelyanski, L. and Gershoni, J. M. 2001. The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd. Nucleic Acids Res. 29:E50.
    • (2001) Nucleic Acids Res , vol.29
    • Enshell-Seijffers, D.1    Smelyanski, L.2    Gershoni, J.M.3
  • 34
    • 43549089490 scopus 로고    scopus 로고
    • Phage display selection and analysis of Ab-binding epitopes
    • Chapter 9:Unit 9.8.1-9.8.27
    • Enshell-Seijffers, D. and Gershoni, J. M. 2002. Phage display selection and analysis of Ab-binding epitopes. Curr. Protoc. Immunol. Chapter 9:Unit 9.8.1-9.8.27.
    • (2002) Curr. Protoc. Immunol.
    • Enshell-Seijffers, D.1    Gershoni, J.M.2
  • 35
    • 20244367576 scopus 로고    scopus 로고
    • Bivalence of EGF-like ligands drives the ErbB signaling network
    • Tzahar, E., Pinkas-Kramarski, R., Moyer, J. D. et al. 1997. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J. 16:4938.
    • (1997) EMBO J , vol.16 , pp. 4938
    • Tzahar, E.1    Pinkas-Kramarski, R.2    Moyer, J.D.3
  • 36
    • 13344284648 scopus 로고    scopus 로고
    • An immunological approach reveals biological differences between the two NDF/ heregulin receptors, ErbB-3 and ErbB-4
    • Chen, X., Levkowitz, G., Tzahar, E. et al. 1996. An immunological approach reveals biological differences between the two NDF/ heregulin receptors, ErbB-3 and ErbB-4. J. Biol. Chem. 271:7620.
    • (1996) J. Biol. Chem. , vol.271 , pp. 7620
    • Chen, X.1    Levkowitz, G.2    Tzahar, E.3
  • 37
    • 0028819660 scopus 로고
    • Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model
    • Goldstein, N. I., Prewett, M., Zuklys, K., Rockwell, P. and Mendelsohn, J. 1995. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res. 1:1311.
    • (1995) Clin. Cancer Res. , vol.1 , pp. 1311
    • Goldstein, N.I.1    Prewett, M.2    Zuklys, K.3    Rockwell, P.4    Mendelsohn, J.5
  • 38
    • 44449099824 scopus 로고    scopus 로고
    • Synthesis and application of peptide dendrimers as protein mimetics
    • Chapter 9:Unit 9.6
    • Tam, J. P. and Spetzler, J. C. 2001. Synthesis and application of peptide dendrimers as protein mimetics. Curr. Protoc. Immunol. Chapter 9:Unit 9.6.
    • (2001) Curr. Protoc. Immunol.
    • Tam, J.P.1    Spetzler, J.C.2
  • 39
    • 0142195767 scopus 로고    scopus 로고
    • The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1
    • Enshell-Seijffers, D., Denisov, D., Groisman, B. et al. 2003. The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J. Mol. Biol. 334:87.
    • (2003) J. Mol. Biol. , vol.334 , pp. 87
    • Enshell-Seijffers, D.1    Denisov, D.2    Groisman, B.3
  • 40
    • 34249886331 scopus 로고    scopus 로고
    • Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm
    • Bublil, E. M., Freund, N. T., Mayrose, I. et al. 2007. Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm. Proteins 68:294.
    • (2007) Proteins , vol.68 , pp. 294
    • Bublil, E.M.1    Freund, N.T.2    Mayrose, I.3
  • 41
    • 0037434791 scopus 로고    scopus 로고
    • Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
    • Cho, H. S., Mason, K., Ramyar, K. X. et al. 2003. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421:756.
    • (2003) Nature , vol.421 , pp. 756
    • Cho, H.S.1    Mason, K.2    Ramyar, K.X.3
  • 42
    • 69849095169 scopus 로고    scopus 로고
    • Automated detection of conformational epitopes using phage display peptide sequences
    • Negi, S. S. and Braun, W. 2009. Automated detection of conformational epitopes using phage display peptide sequences. Bioinform. Biol. Insights 3:71.
    • (2009) Bioinform. Biol. Insights , vol.3 , pp. 71
    • Negi, S.S.1    Braun, W.2
  • 44
    • 65449188232 scopus 로고    scopus 로고
    • Jalview Version 2-a multiple sequence alignment editor and analysis workbench
    • Waterhouse, A. M., Procter, J. B., Martin, D. M., Clamp, M. and Barton, G. J. 2009. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189.
    • (2009) Bioinformatics , vol.25 , pp. 1189
    • Waterhouse, A.M.1    Procter, J.B.2    Martin, D.M.3    Clamp, M.4    Barton, G.J.5
  • 45
    • 0020475449 scopus 로고
    • A simple method for displaying the hydropathic character of a protein
    • Kyte, J. and Doolittle, R. F. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105.
    • (1982) J. Mol. Biol. , vol.157 , pp. 105
    • Kyte, J.1    Doolittle, R.F.2
  • 46
    • 0028917153 scopus 로고
    • Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage
    • Meola, A., Delmastro, P., Monaci, P. et al. 1995. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J. Immunol. 154:3162.
    • (1995) J. Immunol. , vol.154 , pp. 3162
    • Meola, A.1    Delmastro, P.2    Monaci, P.3
  • 47
    • 0030796474 scopus 로고    scopus 로고
    • Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration
    • Delmastro, P., Meola, A., Monaci, P., Cortese, R. and Galfre, G. 1997. Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine 15:1276.
    • (1997) Vaccine , vol.15 , pp. 1276
    • Delmastro, P.1    Meola, A.2    Monaci, P.3    Cortese, R.4    Galfre, G.5
  • 48
    • 0031759241 scopus 로고    scopus 로고
    • Peptide mimotopes displayed by phage inhibit antibody binding to bet v. 1, the major birch pollen allergen, and induce specific IgG response in mice
    • Jensen-jarolim, E., Leitner, A., Kalchhauser, H. et al. 1998. Peptide mimotopes displayed by phage inhibit antibody binding to bet v. 1, the major birch pollen allergen, and induce specific IgG response in mice. FASEB J. 12:1635.
    • (1998) FASEB J , vol.12 , pp. 1635
    • Jensen-jarolim, E.1    Leitner, A.2    Kalchhauser, H.3
  • 49
    • 0033729843 scopus 로고    scopus 로고
    • Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE
    • Ganglberger, E., Grunberger, K., Sponer, B. et al. 2000. Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE. FASEB J. 14:2177.
    • (2000) FASEB J , vol.14 , pp. 2177
    • Ganglberger, E.1    Grunberger, K.2    Sponer, B.3
  • 50
    • 77955657213 scopus 로고    scopus 로고
    • Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope
    • Rakover, I. S., Zabavnik, N., Kopel, R., Paz-Rozner, M. and Solomon, B. 2010. Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope. J. Neuroimmunol. 225:68.
    • (2010) J. Neuroimmunol. , vol.225 , pp. 68
    • Rakover, I.S.1    Zabavnik, N.2    Kopel, R.3    Paz-Rozner, M.4    Solomon, B.5
  • 51
    • 13544277841 scopus 로고    scopus 로고
    • EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials
    • Lavie, V., Becker, M., Cohen-Kupiec, R. et al. 2004. EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials. J. Mol. Neurosci. 24:105.
    • (2004) J. Mol. Neurosci. , vol.24 , pp. 105
    • Lavie, V.1    Becker, M.2    Cohen-Kupiec, R.3
  • 52
    • 33845665424 scopus 로고    scopus 로고
    • Comparison of phage pVIII and KLH as vector in inducing the production of cytokines in C57BL/6J mice
    • Su, Q. P., Wen, D. Z., Yang, Q., Zhang, Y. H., Liu, C. and Wang, L. 2007. Comparison of phage pVIII and KLH as vector in inducing the production of cytokines in C57BL/6J mice. Vaccine 25:970.
    • (2007) Vaccine , vol.25 , pp. 970
    • Su, Q.P.1    Wen, D.Z.2    Yang, Q.3    Zhang, Y.H.4    Liu, C.5    Wang, L.6
  • 53
    • 0001331728 scopus 로고
    • Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system
    • Tam, J. P. 1988. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl Acad. Sci. USA 85:5409.
    • (1988) Proc. Natl Acad. Sci. USA , vol.85 , pp. 5409
    • Tam, J.P.1
  • 54
    • 0024310231 scopus 로고
    • Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B- cell epitopes
    • Tam, J. P. and Lu, Y. A. 1989. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B- cell epitopes. Proc. Natl Acad. Sci. USA 86:9084.
    • (1989) Proc. Natl Acad. Sci. USA , vol.86 , pp. 9084
    • Tam, J.P.1    Lu, Y.A.2
  • 55
    • 0028960723 scopus 로고
    • Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, dydrazone and thiazolidine linkages
    • Shao, J. and Tam, J. P. 1995. Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, dydrazone and thiazolidine linkages. J. Am. Chem. Soc. 117:3893.
    • (1995) J. Am. Chem. Soc. , vol.117 , pp. 3893
    • Shao, J.1    Tam, J.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.